Table 1. Helicobacter Pylori Infection Treatment Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Helicobacter Pylori Infection Treatment Market Restraints

Table 3. Helicobacter Pylori Infection Treatment Market Trends

Table 4. Helicobacter Pylori Infection Treatment Industry Policy

Table 5. Global Helicobacter Pylori Infection Treatment Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Company (2018-2023)

Table 7. Global Helicobacter Pylori Infection Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Helicobacter Pylori Infection Treatment Mergers & Acquisitions, Expansion Plans

Table 9. Global Helicobacter Pylori Infection Treatment Manufacturers Product Type

Table 10. China Helicobacter Pylori Infection Treatment Revenue by Company (2018-2023) & (US$ million)

Table 11. China Helicobacter Pylori Infection Treatment Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Helicobacter Pylori Infection Treatment Upstream (Raw Materials)

Table 13. Global Helicobacter Pylori Infection Treatment Typical Customers

Table 14. Helicobacter Pylori Infection Treatment Typical Distributors

Table 15. By Type, Global Helicobacter Pylori Infection Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Helicobacter Pylori Infection Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Helicobacter Pylori Infection Treatment Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Helicobacter Pylori Infection Treatment Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Helicobacter Pylori Infection Treatment Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Helicobacter Pylori Infection Treatment Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Helicobacter Pylori Infection Treatment Revenue Market Share, 2018-2029

Table 22. Cumberland Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 23. Cumberland Pharmaceuticals Company Profile and Main Business

Table 24. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 25. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 26. Cumberland Pharmaceuticals Recent Developments

Table 27. Eisai Co. Company Information, Head Office, Market Area and Industry Position

Table 28. Eisai Co. Company Profile and Main Business

Table 29. Eisai Co. Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 30. Eisai Co. Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 31. Eisai Co. Recent Developments

Table 32. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

Table 33. Bio-Rad Laboratories Company Profile and Main Business

Table 34. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 35. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 36. Bio-Rad Laboratories Recent Developments

Table 37. F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position

Table 38. F. Hoffmann-La Roche Company Profile and Main Business

Table 39. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 40. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 41. F. Hoffmann-La Roche Recent Developments

Table 42. Alpha Laboratories Company Information, Head Office, Market Area and Industry Position

Table 43. Alpha Laboratories Company Profile and Main Business

Table 44. Alpha Laboratories Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 45. Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 46. Alpha Laboratories Recent Developments

Table 47. Biohit Company Information, Head Office, Market Area and Industry Position

Table 48. Biohit Company Profile and Main Business

Table 49. Biohit Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 50. Biohit Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 51. Biohit Recent Developments

Table 52. Phathom Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 53. Phathom Pharmaceuticals Company Profile and Main Business

Table 54. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 55. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 56. Phathom Pharmaceuticals Recent Developments

Table 57. Redhill Biopharma Company Information, Head Office, Market Area and Industry Position

Table 58. Redhill Biopharma Company Profile and Main Business

Table 59. Redhill Biopharma Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 60. Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 61. Redhill Biopharma Recent Developments

Table 62. Takeda Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 63. Takeda Pharmaceuticals Company Profile and Main Business

Table 64. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 65. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 66. Takeda Pharmaceuticals Recent Developments

Table 67. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 68. AbbVie Company Profile and Main Business

Table 69. AbbVie Helicobacter Pylori Infection Treatment Models, Specifications and Application

Table 70. AbbVie Helicobacter Pylori Infection Treatment Revenue and Gross Margin, 2018-2023

Table 71. AbbVie Recent Developments

List of Figure

Figure 1. Helicobacter Pylori Infection Treatment Picture

Figure 2. Global Helicobacter Pylori Infection Treatment Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Helicobacter Pylori Infection Treatment Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Helicobacter Pylori Infection Treatment Market Share of Global

Figure 5. Global Helicobacter Pylori Infection Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Helicobacter Pylori Infection Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Helicobacter Pylori Infection Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Helicobacter Pylori Infection Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Helicobacter Pylori Infection Treatment Industry Chain

Figure 10. Bismuth-quadruple Therapy

Figure 11. Concomitant Therapy

Figure 12. Levofloxacin Triple Therapy

Figure 13. Bismuth Therapy

Figure 14. High-dose Dual Therapy

Figure 15. By Type, Global Helicobacter Pylori Infection Treatment Revenue, 2018-2029, US$ Million

Figure 16. By Type, Global Helicobacter Pylori Infection Treatment Revenue Market Share, 2018-2029

Figure 17. Hospitals

Figure 18. Diagnostics Laboratories

Figure 19. Clinics

Figure 20. By Application, Global Helicobacter Pylori Infection Treatment Revenue, 2018-2029, US$ Million

Figure 21. By Application, Global Helicobacter Pylori Infection Treatment Revenue Market Share, 2018-2029

Figure 22. By Region, Global Helicobacter Pylori Infection Treatment Revenue Market Share, 2018-2029

Figure 23. North America Helicobacter Pylori Infection Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, North America Helicobacter Pylori Infection Treatment Revenue Market Share, 2018-2023

Figure 25. Europe Helicobacter Pylori Infection Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country, Europe Helicobacter Pylori Infection Treatment Revenue Market Share, 2018-2023

Figure 27. Asia Pacific Helicobacter Pylori Infection Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country/Region, Asia Pacific Helicobacter Pylori Infection Treatment Revenue Market Share, 2018-2023

Figure 29. South America Helicobacter Pylori Infection Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. By Country, South America Helicobacter Pylori Infection Treatment Revenue Market Share, 2018-2023

Figure 31. Middle East & Africa Helicobacter Pylori Infection Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 32. U.S. Helicobacter Pylori Infection Treatment Revenue, 2018-2029, (US$ Million)

Figure 33. By Company, U.S. Helicobacter Pylori Infection Treatment Market Share, 2018-2023

Figure 34. By Type, U.S. Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 35. By Application, U.S. Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 36. Europe Helicobacter Pylori Infection Treatment Revenue, 2018-2029, (US$ Million)

Figure 37. By Company, Europe Helicobacter Pylori Infection Treatment Market Share, 2018-2023

Figure 38. By Type, Europe Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 39. By Application, Europe Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 40. China Helicobacter Pylori Infection Treatment Revenue, 2018-2029, (US$ Million)

Figure 41. By Company, China Helicobacter Pylori Infection Treatment Market Share, 2018-2023

Figure 42. By Type, China Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 43. By Application, China Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 44. Japan Helicobacter Pylori Infection Treatment Revenue, 2018-2029, (US$ Million)

Figure 45. By Company, Japan Helicobacter Pylori Infection Treatment Market Share, 2018-2023

Figure 46. By Type, Japan Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 47. By Application, Japan Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 48. South Korea Helicobacter Pylori Infection Treatment Revenue, 2018-2029, (US$ Million)

Figure 49. By Company, South Korea Helicobacter Pylori Infection Treatment Market Share, 2018-2023

Figure 50. By Type, South Korea Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 51. By Application, South Korea Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 52. Southeast Asia Helicobacter Pylori Infection Treatment Revenue, 2018-2029, (US$ Million)

Figure 53. By Company, Southeast Asia Helicobacter Pylori Infection Treatment Market Share, 2018-2023

Figure 54. By Type, Southeast Asia Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 55. By Application, Southeast Asia Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 56. India Helicobacter Pylori Infection Treatment Revenue, 2018-2029, (US$ Million)

Figure 57. By Company, India Helicobacter Pylori Infection Treatment Market Share, 2018-2023

Figure 58. By Type, India Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 59. By Application, India Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 60. Middle East & Asia Helicobacter Pylori Infection Treatment Revenue, 2018-2029, (US$ Million)

Figure 61. By Company, Middle East & Asia Helicobacter Pylori Infection Treatment Market Share, 2018-2023

Figure 62. By Type, Middle East & Asia Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 63. By Application, Middle East & Asia Helicobacter Pylori Infection Treatment Revenue Market Share, 2022 VS 2029

Figure 64. Research Methodology

Figure 65. Breakdown of Primary Interviews

Figure 66. Bottom-up Approaches

Figure 67. Top-down Approaches